Veracyte to Participate in Upcoming Investor Conferences
15 Mayo 2024 - 4:04PM
Business Wire
Veracyte, Inc. (Nasdaq: VCYT) a leading cancer diagnostics
company, today announced it will participate in the following
investor conferences.
- Leerink Partners 2024 Healthcare Crossroads Conference –
Austin, TX Fireside Chat on May 29th at 12:20 p.m. Eastern
Time
- William Blair 44th Annual Growth Stock Conference – Chicago,
IL Presentation on June 4th at 5:40 p.m. Eastern Time
Live audio webcasts of the company’s presentations will be
available by visiting Veracyte’s website at
http://investor.veracyte.com/events-presentations. A replay of the
webcasts will be available following the conclusion of the live
presentation broadcast.
About Veracyte
Veracyte (Nasdaq: VCYT) is a global diagnostics company whose
vision is to transform cancer care for patients all over the world.
We empower clinicians with the high-value insights they need to
guide and assure patients at pivotal moments in the race to
diagnose and treat cancer. Our Veracyte Diagnostics Platform
delivers high-performing cancer tests that are fueled by broad
genomic and clinical data, deep bioinformatic and AI capabilities,
and a powerful evidence-generation engine, which ultimately drives
durable reimbursement and guideline inclusion for our tests, along
with new insights to support continued innovation and pipeline
development. For more information, please visit www.veracyte.com or
follow us on LinkedIn or X (Twitter).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240515789405/en/
Investors: Shayla Gorman investors@veracyte.com (619)
393-1545
Media: Tracy Morris media@veracyte.com (650) 380-4413
Veracyte (NASDAQ:VCYT)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Veracyte (NASDAQ:VCYT)
Gráfica de Acción Histórica
De May 2023 a May 2024